Metformin Bioequivalence Study [Design Issues]

posted by AB661 – India, 2020-08-19 11:22 (1486 d 09:38 ago) – Posting: # 21888
Views: 1,789

Dear Colleagues,

I need your advice please for Metformin Oral Solution. As per Orange book it have AB TE code.
Should BE required to support ANDA application?

Metformin has non-linear pharmacokinetics. There No OGD BE guidance for this product . Whether BE study should be conducted with 500 dose or 1000 mg dose.

I would be grateful if someone could guide me.

With regards
AB

Complete thread:

UA Flag
Activity
 Admin contact
23,224 posts in 4,878 threads, 1,654 registered users;
25 visitors (0 registered, 25 guests [including 8 identified bots]).
Forum time: 21:01 CEST (Europe/Vienna)

One of the symptoms of an approaching nervous breakdown
is the belief that one’s work is terribly important.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5